Bibliography
Varbanov, H., Valiahdi, S. M., Legin, A. A., Jakupec, M. A., Roller, A., Galanski, M. S., & Keppler, B. K. (2011). Synthesis and characterization of novel bis(carboxylato)dichloridobis(ethylamine)platinum(IV) complexes with higher cytotoxicity than cisplatin. European Journal of Medicinal Chemistry, 46(11), 5456â5464.
References
29
Referenced
72
10.1038/205698a0
/ Nature / Inhibition of cell division in Escherichia coli by electrolysis products from a platinum electrode by Rosenberg (1965)10.1039/c0dt00292e
/ Dalton Trans. / The status of platinum anticancer drugs in the clinic and in clinical trials by Wheate (2010)10.1021/jm070280u
/ J. Med. Chem. / Basis for design and development of platinum(IV) anticancer complexes by Hall (2007)10.2174/157489206777442287
/ Recent Pat. Anticancer Drug Discov. / Recent developments in the field of anticancer platinum complexes by Galanski (2006)10.2174/0929867054637626
/ Curr. Med. Chem. / Update of the preclinical situation of anticancer platinum complexes: novel design strategies and innovative analytical approaches by Galanski (2005){'issue': '3', 'key': '10.1016/j.ejmech.2011.09.006_bib6', 'first-page': '709', 'article-title': 'Phase I and pharmacokinetic study of ormaplatin (tetraplatin, NSC 363812) administered on a day 1 and day 8 schedule', 'volume': '54', 'author': 'Schilder', 'year': '1994', 'journal-title': 'Cancer Res.'}
/ Cancer Res. / Phase I and pharmacokinetic study of ormaplatin (tetraplatin, NSC 363812) administered on a day 1 and day 8 schedule by Schilder (1994){'year': '2007', 'series-title': 'G.B. Inc, Orplanta. Satraplatin Capsules, in Advisory Committee Briefing Document', 'key': '10.1016/j.ejmech.2011.09.006_bib7'}
/ G.B. Inc, Orplanta. Satraplatin Capsules, in Advisory Committee Briefing Document (2007){'year': '2008', 'series-title': 'Withdrawal Assessment Report for Orplanta', 'key': '10.1016/j.ejmech.2011.09.006_bib8'}
/ Withdrawal Assessment Report for Orplanta (2008)- http://www.clinicaltrials.gov, U.S National Library of Medicine, Bethesda, 1993.
10.1111/j.1432-1033.1995.tb20301.x
/ Eur. J. Biochem. / DNA interactions of antitumor platinum(IV) complexes by Novakova (1995)10.1016/S0020-1693(99)00613-1
/ Inorg. Chim. Acta / Is reduction required for antitumor activity of platinum(IV) compounds? Characterisation of a platinum(IV)-nucleotide adduct [enPt(OCOCH3)3(5′-GMP)] by NMR spectroscopy and ESI-MS by Galanski (2000)10.1071/CH9950793
/ Aust. J. Chem. / The influence of the axial ligands of a series of platinum(IV) anti-cancer complexes on their reduction to platinum(II) and reaction with DNA by Ellis (1995)10.1021/ic971047x
/ Inorg. Chem. / Reduction and anticancer activity of platinum(IV) complexes by Choi (1998){'key': '10.1016/j.ejmech.2011.09.006_bib14', 'first-page': '4539', 'article-title': 'In vitro biotransformations of tetrachloro(d, l-trans)-1,2-diaminocyclohexaneplatinum(IV) (tetraplatin) in rat plasma', 'volume': '50', 'author': 'Chaney', 'year': '1990', 'journal-title': 'Cancer Res.'}
/ Cancer Res. / In vitro biotransformations of tetrachloro(d, l-trans)-1,2-diaminocyclohexaneplatinum(IV) (tetraplatin) in rat plasma by Chaney (1990){'key': '10.1016/j.ejmech.2011.09.006_bib15', 'first-page': '3533', 'article-title': 'Identification of cis-dichloro-bis-isopropylamine platinum(II) as a major metabolite of iproplatin in humans', 'volume': '48', 'author': 'Pendyala', 'year': '1988', 'journal-title': 'Cancer Res.'}
/ Cancer Res. / Identification of cis-dichloro-bis-isopropylamine platinum(II) as a major metabolite of iproplatin in humans by Pendyala (1988)10.1016/S0378-4347(00)00498-9
/ J. Chromatogr. B. / Speciation of platinum compounds: a review of recent applications in studies of platinum anticancer drugs by Barefoot (2001)10.1002/ejic.200600108
/ Eur. J. Inorg. Chem. / An entry to novel platinum complexes: carboxylation of dihydroxoplatinum(IV) complexes with succinic anhydride and subsequent derivatization by Reithofer (2006)10.1021/jm070897b
/ J. Med. Chem. / Novel di- and tetracarboxylatoplatinum(IV) complexes. Synthesis, characterization, cytotoxic activity, and DNA platination by Reithofer (2007)10.1016/j.jinorgbio.2008.07.006
/ J. Inorg. Biochem. / Novel bis(carboxylato)dichlorido(ethane-1,2-diamine)platinum(IV) complexes with exceptionally high cytotoxicity by Reithofer (2008)10.1002/cbdv.200890197
/ Chem. Biodiv / Novel endothall containing platinum(IV) complexes – synthesis, characterization, and cytotoxic activity by Reithofer (2008)10.1002/elps.200900522
/ Electrophoresis / The first example of MEEKC-ICP-MS coupling and its application for the analysis of anticancer platinum complexes by Bytzek (2010)10.1016/j.jinorgbio.2010.09.006
/ J. Inorg. Biochem. / Tuning of lipophilicity and cytotoxic potency by structural variation of anticancer platinum(IV) complexes by Reithofer (2011)10.1021/jm0506468
/ J. Med. Chem. / Synthesis and characterization of platinum(IV) anticancer drugs with functionalized aromatic carboxylate ligands: influence of the ligands on drug efficacies and uptake by Ang (2005)10.1016/j.jinorgbio.2007.12.029
/ J. Inorg. Biochem. / Calculation of lipophilicity for Pt(II) complexes: experimental comparison of several methods by Tetko (2008){'key': '10.1016/j.ejmech.2011.09.006_bib25', 'first-page': '193', 'article-title': 'A rapid method for the synthesis of cis-[Pt(NH3)2Cl2]', 'volume': '8', 'author': 'Dhara', 'year': '1970', 'journal-title': 'Indian J. Chem.'}
/ Indian J. Chem. / A rapid method for the synthesis of cis-[Pt(NH3)2Cl2] by Dhara (1970){'year': '2004', 'series-title': 'SAINT-Plus, Version 7.06a and APEX2', 'key': '10.1016/j.ejmech.2011.09.006_bib26'}
/ SAINT-Plus, Version 7.06a and APEX2 (2004)10.1107/S0108767307043930
/ Acta Cryst. / A short history of SHELX by Sheldrick (2008){'year': '1976', 'series-title': 'Report ORNL-5138', 'author': 'Johnson', 'key': '10.1016/j.ejmech.2011.09.006_bib28'}
/ Report ORNL-5138 by Johnson (1976){'year': '1995', 'series-title': 'OECD Guidelines for Testing of Chemicals, No. 107', 'key': '10.1016/j.ejmech.2011.09.006_bib29'}
/ OECD Guidelines for Testing of Chemicals, No. 107 (1995)
Dates
Type | When |
---|---|
Created | 13 years, 11 months ago (Sept. 10, 2011, 5:37 a.m.) |
Deposited | 1 year, 6 months ago (Jan. 25, 2024, 5:30 a.m.) |
Indexed | 2 months, 4 weeks ago (May 26, 2025, 4:05 a.m.) |
Issued | 13 years, 9 months ago (Nov. 1, 2011) |
Published | 13 years, 9 months ago (Nov. 1, 2011) |
Published Print | 13 years, 9 months ago (Nov. 1, 2011) |
Funders
4
Universität Wien
10.13039/501100003065
Region: Europe
pri (Universities (academic only))
Labels
1
- University of Vienna
Österreichische Forschungsförderungsgesellschaft
10.13039/501100004955
Region: Europe
gov (National government)
Labels
5
- Austrian Research Promotion Agency
- Die Österreichische Forschungsförderungsgesellschaft
- Österreichische Forschungsförderungsgesellschaft mbH
- FFG – Austria
- FFG
Austrian Science Fund
10.13039/501100002428
Region: Europe
gov (National government)
Labels
8
- Fonds zur Förderung der Wissenschaftlichen Forschung
- FWF Der Wissenschaftsfonds
- FWF Austrian Science Fund
- Der Wissenschaftsfonds FWF
- Österreichischer Wissenschaftsfonds
- FWF
- FFWF
- FWF EN
Awards
1
- COST D39
Rat für Forschung und Technologieentwicklung
10.13039/501100010266
Region: Europe
gov (National government)
Labels
3
- Austrian Council
- Austrian Council for Research and Technology Development
- RFT
@article{Varbanov_2011, title={Synthesis and characterization of novel bis(carboxylato)dichloridobis(ethylamine)platinum(IV) complexes with higher cytotoxicity than cisplatin}, volume={46}, ISSN={0223-5234}, url={http://dx.doi.org/10.1016/j.ejmech.2011.09.006}, DOI={10.1016/j.ejmech.2011.09.006}, number={11}, journal={European Journal of Medicinal Chemistry}, publisher={Elsevier BV}, author={Varbanov, Hristo and Valiahdi, Seied M. and Legin, Anton A. and Jakupec, Michael A. and Roller, Alexander and Galanski, Mathea S. and Keppler, Bernhard K.}, year={2011}, month=nov, pages={5456–5464} }